ANKRD26 and Thrombocytopenia: Once a diagnosis of inherited thrombocytopenia with germline mutation in RUNX1, ANKRD26, or ETV6 is established, close and long-term surveillance is mandatory given the lifelong increased risk of developing hematologic malignancies.